Our Board of Trustees is responsible for the strategic management of the organisation and delivery of our charitable objectives.
Our Trustees are not remunerated, they hold voluntary posts. Our Board is made up of very experienced and talented people, many of whom have a direct personal understanding of inherited sight loss. It also has a legal responsibility to ensure the charity complies with current legislation and governance best practice.
Ashley is currently the Vice President & Chief Financial Officer, International for Vertex Pharmaceuticals.
Colin McArthur re-joined the board in 2024 after serving as a trustee between (January 2008 and September 2019).
Dr Graham undertook research into the basic mechanisms of retinal vasculitis, inflammation of the blood vessels in the retina, and is an important cause of poor vision in patients with uveitis, inflammation of the uveal tract.
Lucy has worked with a number of charities in volunteer roles including fundraising and assistance dog training.
Martin's son was diagnosed with Stargardt’s at a young age which has led Martin to take a close interest in the progress of research into Retinal disease.
Lynda Cantor was a founder member of the charity in 1975 and one of our original trustees
Prof John Marshall is the Frost Professor of Ophthalmology at the Institute of Ophthalmology at University College London.
Roger has retinitis pigmentosa, as do his son, mother and grandfather. He was officially diagnosed aged 16.
Simon spent 40 years as a consultant ophthalmic surgeon at the North Hampshire Hospital in Basingstoke.
Vanessa is the General Counsel at the Alan Turing Institute, the UK’s national data science and artificial intelligence research institute.
